NIVI Development A/S
Public limited companyCVR 44372835HellerupActive
NIVI Development A/S is a public limited company, based in Hellerup, active in research and experimental development on natural sciences and engineering, founded in 2023. The company made a loss in both 2024 and 2025, most recently DKK 19.8m. Equity grew to DKK 3.5m in 2025. 6 other companies in the database are registered at the same address.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- The loss grew: from DKK 6.1m to DKK 19.8m (2024 → 2025).
- Equity rose 53% (2024 → 2025), to DKK 3.5m.
Employees
- 2 more employees than a year earlier: 9 (07/2026) against 7 (07/2025).
Management and owners, last 24 months
- New in management: Marianne Holm (board member, 26/05/2025), Peter Andersen (board member, 10/12/2025) and Pelle Kristoffer Munk-Poulsen (chair of the board, 10/12/2025) (+4).
- Stepped down: Pelle Kristoffer Munk-Poulsen (board member, 09/12/2025), Peter Andersen (chair of the board, 09/12/2025) and Erika Johanna Söderberg Johnsson (board member, 02/02/2026) (+2).
Registrations, last 24 months
- 30/09/2026: Name changed from NIVI Development P/S to NIVI Development A/S
- 28/01/2025: Name changed from NVAC P/S to NIVI Development P/S
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2024–2025 · amounts in DKK thousandEquity and net profit
| 2024 | 2025 | Change | |
|---|---|---|---|
| Revenue | not stated | not stated | – |
| Gross profit | −3,199 | −9,155 | −186.2% |
| Operating profit (EBIT) | −6,121 | −19,789 | −223.3% |
| Net profit | −6,089 | −19,783 | −224.9% |
| Total assets | 3,812 | 7,283 | +91.1% |
| Equity | 2,311 | 3,528 | +52.7% |
| Liabilities | 1,501 | 3,755 | +150.2% |
| Cash and cash equivalents | 3,456 | 7,005 | +102.7% |
| Average number of employees | 2 | 6 | +200% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresLoss for 2 years in a row
Net result has been negative in 2024–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
2 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 10/06/2026 | The company | PDF not statedXBRL |
| 2024 | 16/10/2023 – 31/12/2024 | 04/07/2025 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 69,634of 69,742 Better than 0% | No. 17,584of 69,964 Better than 75% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 306of 323 Better than 5% | No. 110of 329 Better than 67% |
| Companies that are founded within the last five years16,662 companies in the comparison | No. 16,579of 16,614 Better than 0% | No. 1,660of 16,661 Better than 90% |
| All companies of type A/S18,025 companies in the comparison | No. 17,688of 17,786 Better than 1% | No. 12,794of 18,024 Better than 29% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- NIVI Development A/S−DKK 9.2m
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- NIVI Development A/S−DKK 19.8m
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- NIVI Development A/SDKK 3.5m
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- NIVI Development A/S9
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Novo Nordisk Fonden100%
Management
7 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Else Marie Hansen | CEO | 10/12/2025 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Charlotte Bonefeld | Board member | 01/05/2024 |
| Marianne Holm | Board member | 26/05/2025 |
| Peter Andersen | Board member | 10/12/2025 |
| Pelle Kristoffer Munk-Poulsen | Chair of the board | 10/12/2025 |
| Arnauld Michel Didierlaurent | Board member | 03/06/2026 |
| Nadia Gabriela Tornieporth | Board member | 03/06/2026 |
- Founders
- Novo Nordisk Fonden, NNF General Partner ApS
Former management (8)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Peter Andersen | Board member | 16/10/2023 | 30/04/2024 |
| Pelle Kristoffer Munk-Poulsen | Board member | 16/10/2023 | 09/12/2025 |
| Mads Krogsgaard Thomsen | Chair of the board | 16/10/2023 | 01/05/2024 |
| Søren Nedergaard | CEO | 16/10/2023 | 30/04/2024 |
| Peter Andersen | Chair of the board | 01/05/2024 | 09/12/2025 |
| Erika Johanna Söderberg Johnsson | Board member | 01/05/2024 | 02/02/2026 |
| Nicholas Aubrey Corbett Jackson | CEO | 01/05/2024 | 11/06/2025 |
| Erika Johanna Söderberg Johnsson | CEO | 11/06/2025 | 01/12/2025 |
Signing rule: Selskabet tegnes af formanden for bestyrelsen i forening med ét medlem af bestyrelsen eller af formanden for bestyrelsen i forening med en direktør.
Address and production units
1 active production unitsTuborg Havnevej 19
2900 Hellerup
Gentofte Municipality · Postcode 2900
Other companies at the address (6)
- Novo Holdings Business & People Support P/SBusiness and other management consultancy activities
- Novo Holdings A/STrusts, estates and similar financial entities
- Novo Holdings DK Investment Advisor P/SBusiness and other management consultancy activities
- Echo TopCo A/SNon-financial holding companies
- NH Aifm P/SOther financial service activities n.e.c.
| Production unit | Address | Employees | P number |
|---|---|---|---|
| NIVI Development A/S | Tuborg Havnevej 19, 2900 Hellerup | 9 | 1029752288 |
Purpose
Selskabets formål er at drive virksomhed inden for design, udvikling og kliniske undersøgelser af vacciner samt at drive anden i forbindelse hermed stående virksomhed.
The purpose is quoted from the register in Danish.
Changes year by year
30 registered events20265 changesname 1 · accounts 1 · management 3
- NameName changed from NIVI Development P/S to NIVI Development A/S
- AccountsAnnual report for 2025 published
- ManagementNadia Gabriela Tornieporth appointed board member
- ManagementArnauld Michel Didierlaurent appointed board member
- ManagementErika Johanna Söderberg Johnsson stepped down as board member
202512 changesmanagement 9 · accounts 1 · name 1 · industry 1
- ManagementPeter Andersen appointed board member
- ManagementElse Marie Hansen appointed ceo
- ManagementPelle Kristoffer Munk-Poulsen appointed chair of the board
- ManagementPeter Andersen stepped down as chair of the board
- ManagementPelle Kristoffer Munk-Poulsen stepped down as board member
- ManagementErika Johanna Söderberg Johnsson stepped down as ceo
- AccountsAnnual report for 2024 published
- ManagementErika Johanna Söderberg Johnsson appointed ceo
- ManagementNicholas Aubrey Corbett Jackson stepped down as ceo
- ManagementMarianne Holm appointed board member
- NameName changed from NVAC P/S to NIVI Development P/S
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
20247 changesmanagement 7
- ManagementCharlotte Bonefeld appointed board member
- ManagementNicholas Aubrey Corbett Jackson appointed ceo
- ManagementErika Johanna Söderberg Johnsson appointed board member
- ManagementPeter Andersen appointed chair of the board
- ManagementMads Krogsgaard Thomsen stepped down as chair of the board
- ManagementSøren Nedergaard stepped down as ceo
- ManagementPeter Andersen stepped down as board member
20236 changesfounded 1 · management 4 · ownership 1
- FoundedRegistered as NVAC P/S
- ManagementPelle Kristoffer Munk-Poulsen appointed board member
- ManagementSøren Nedergaard appointed ceo
- ManagementPeter Andersen appointed board member
- ManagementMads Krogsgaard Thomsen appointed chair of the board
- OwnershipNOVO NORDISK FONDEN registered as owner (100%)
Related companies
Same industry in Gentofte
- Pharmaceutical Research Associates Denmark ApS50 employees
- Novo Nordisk Clinical Innovation Centre A/S32 employees
- Bioporto Diagnostics A/S28 employees
- Bioporto A/S8 employees
- Protein Frontiers ApS4 employees
- Aetas Labs ApS4 employees
Same people in management
- Novo Nordisk A/Svia Mads Krogsgaard Thomsen
- Servier Symphogen A/Svia Mads Krogsgaard Thomsen
- Life A/Svia Søren Nedergaard
- Quantum Foundry Copenhagen A/Svia Mads Krogsgaard Thomsen
- Novo Nordisk Foundation Cellerator A/Svia Erika Johanna Söderberg Johnsson
- BII Holdings A/Svia Mads Krogsgaard Thomsen
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.